CN1192248A - 检测调节肥胖症蛋白作用的化合物的方法 - Google Patents
检测调节肥胖症蛋白作用的化合物的方法 Download PDFInfo
- Publication number
- CN1192248A CN1192248A CN96195983A CN96195983A CN1192248A CN 1192248 A CN1192248 A CN 1192248A CN 96195983 A CN96195983 A CN 96195983A CN 96195983 A CN96195983 A CN 96195983A CN 1192248 A CN1192248 A CN 1192248A
- Authority
- CN
- China
- Prior art keywords
- obesity
- compound
- albumen
- response element
- reporter gene
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6897—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids involving reporter genes operably linked to promoters
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/5759—Products of obesity genes, e.g. leptin, obese (OB), tub, fat
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- General Engineering & Computer Science (AREA)
- Toxicology (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Biotechnology (AREA)
- Medicinal Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Analytical Chemistry (AREA)
- Endocrinology (AREA)
- Obesity (AREA)
- Child & Adolescent Psychology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB9510857.7 | 1995-05-30 | ||
GBGB9510857.7A GB9510857D0 (en) | 1995-05-30 | 1995-05-30 | Novel assay |
GB9511602.6 | 1995-06-08 | ||
GBGB9511602.6A GB9511602D0 (en) | 1995-06-08 | 1995-06-08 | Novel assay |
Publications (1)
Publication Number | Publication Date |
---|---|
CN1192248A true CN1192248A (zh) | 1998-09-02 |
Family
ID=26307107
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN96195983A Pending CN1192248A (zh) | 1995-05-30 | 1996-05-28 | 检测调节肥胖症蛋白作用的化合物的方法 |
Country Status (15)
Country | Link |
---|---|
EP (1) | EP0832284A1 (xx) |
JP (1) | JPH11505725A (xx) |
KR (1) | KR19990022134A (xx) |
CN (1) | CN1192248A (xx) |
AU (1) | AU715215B2 (xx) |
BR (1) | BR9608686A (xx) |
CA (1) | CA2222409A1 (xx) |
CZ (1) | CZ379097A3 (xx) |
HU (1) | HUP9801744A3 (xx) |
MX (1) | MX9709360A (xx) |
NO (1) | NO975504L (xx) |
NZ (1) | NZ309777A (xx) |
PL (1) | PL323638A1 (xx) |
TR (1) | TR199701469T1 (xx) |
WO (1) | WO1996038586A1 (xx) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6001968A (en) | 1994-08-17 | 1999-12-14 | The Rockefeller University | OB polypeptides, modified forms and compositions |
US6429290B1 (en) | 1994-08-17 | 2002-08-06 | The Rockefeller University | OB polypeptides, modified forms and derivatives |
WO1997040380A1 (en) * | 1996-04-22 | 1997-10-30 | Merck & Co., Inc. | Leptin assay |
US6007998A (en) * | 1996-04-22 | 1999-12-28 | Merck & Co., Inc. | Leptin assay |
US6001816A (en) * | 1996-06-20 | 1999-12-14 | Merck & Co., Inc. | Gene therapy for leptin deficiency |
CA2270431A1 (en) * | 1996-11-01 | 1998-05-14 | Lee James Beeley | Method for the detection of compounds that modulate the effects of the obese (ob) protein |
IT1293533B1 (it) * | 1997-07-14 | 1999-03-01 | Angeletti P Ist Richerche Bio | Metodo per la selezione di molecole in grado di mimare, inibire o potenziare gli effetti della interazione tra leptina e cellule che |
WO1999023493A1 (en) * | 1997-10-31 | 1999-05-14 | The Rockefeller University | Methods of identifying agents that modulate leptin activity |
AU2668699A (en) * | 1998-02-11 | 1999-08-30 | Beth Israel Deaconess Medical Center | Methods and compositions for modulating leptin activity |
GB9814199D0 (en) * | 1998-06-30 | 1998-08-26 | Univ Buckingham | Novel method |
GB9828087D0 (en) * | 1998-12-18 | 1999-02-17 | Smithkline Beecham Plc | Novel method |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1995008001A1 (en) * | 1993-09-15 | 1995-03-23 | New York University | Dna sequence which binds transcriptional regulatory proteins activated in response to various cytokines and uses thereof |
AU2285995A (en) * | 1994-04-14 | 1995-11-10 | Ligand Pharmaceuticals Incorporated | Dna spacer regulatory elements responsive to cytokines and methods for their use |
-
1996
- 1996-05-28 CA CA002222409A patent/CA2222409A1/en not_active Abandoned
- 1996-05-28 JP JP8536176A patent/JPH11505725A/ja active Pending
- 1996-05-28 TR TR97/01469T patent/TR199701469T1/xx unknown
- 1996-05-28 WO PCT/EP1996/002291 patent/WO1996038586A1/en not_active Application Discontinuation
- 1996-05-28 EP EP96917454A patent/EP0832284A1/en not_active Withdrawn
- 1996-05-28 CZ CZ973790A patent/CZ379097A3/cs unknown
- 1996-05-28 HU HU9801744A patent/HUP9801744A3/hu unknown
- 1996-05-28 MX MX9709360A patent/MX9709360A/es unknown
- 1996-05-28 AU AU60023/96A patent/AU715215B2/en not_active Ceased
- 1996-05-28 KR KR1019970708613A patent/KR19990022134A/ko not_active Application Discontinuation
- 1996-05-28 BR BR9608686A patent/BR9608686A/pt active Search and Examination
- 1996-05-28 CN CN96195983A patent/CN1192248A/zh active Pending
- 1996-05-28 NZ NZ309777A patent/NZ309777A/xx unknown
- 1996-05-28 PL PL96323638A patent/PL323638A1/xx unknown
-
1997
- 1997-11-28 NO NO975504A patent/NO975504L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
PL323638A1 (en) | 1998-04-14 |
EP0832284A1 (en) | 1998-04-01 |
AU6002396A (en) | 1996-12-18 |
NO975504D0 (no) | 1997-11-28 |
HUP9801744A2 (hu) | 1998-10-28 |
MX9709360A (es) | 1998-02-28 |
CA2222409A1 (en) | 1996-12-05 |
KR19990022134A (ko) | 1999-03-25 |
AU715215B2 (en) | 2000-01-20 |
HUP9801744A3 (en) | 2000-06-28 |
NZ309777A (en) | 2000-01-28 |
JPH11505725A (ja) | 1999-05-25 |
TR199701469T1 (xx) | 1998-03-21 |
BR9608686A (pt) | 1999-07-06 |
NO975504L (no) | 1997-11-28 |
WO1996038586A1 (en) | 1996-12-05 |
CZ379097A3 (cs) | 1998-05-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Gray et al. | Induction of arginase I transcription by IL-4 requires a composite DNA response element for STAT6 and C/EBPβ | |
Green et al. | Oestradiol induction of a glucocorticoid-responsive gene by a chimaeric receptor | |
Georgopoulos et al. | Ikaros, an early lymphoid-specific transcription factor and a putative mediator for T cell commitment | |
Bailly et al. | An enhancer element 6 kb upstream of the mouse HNF4α1 promoter is activated by glucocorticoids and liver-enriched transcription factors | |
Schmid et al. | Transcriptional regulation of oxytocin receptor by interleukin-1β and interleukin-6 | |
Navas et al. | Functional characterization of the MODY1 gene mutations HNF4 (R127W), HNF4 (V255M), and HNF4 (E276Q). | |
CN1192248A (zh) | 检测调节肥胖症蛋白作用的化合物的方法 | |
Jain et al. | A single-nucleotide polymorphism in human angiotensinogen gene is associated with essential hypertension and affects glucocorticoid induced promoter activity | |
EP1806404A1 (en) | Isolated nucleic acid molecules which encode T cell inducible factors, or interleukin-21, the proteins encoded, and uses thereof | |
AU778727B2 (en) | Leptin assay | |
Szebenyi et al. | Differential regulation of mannose 6-phosphate receptors and their ligands during the myogenic development of C2 cells. | |
MXPA97009360A (en) | Method for the detection of compounds that modulate the effects of the obesi protein | |
Müller et al. | Differential regulation of the cardiac sodium calcium exchanger promoter in adult and neonatal cardiomyocytes by Nkx2. 5 and serum response factor | |
AU720798B2 (en) | Regulators of UCP2 gene expression | |
Ishikawa et al. | c-fosInduction by Heat, Arsenite, and Cadmium Is Mediated by a Heat Shock Element in Its Promoter | |
CA2270431A1 (en) | Method for the detection of compounds that modulate the effects of the obese (ob) protein | |
Mufson | Induction of immediate early response genes by macrophage colony-stimulating factor in normal human monocytes. | |
EP0640093A1 (en) | Human crabp-i and crabp-ii | |
Chu et al. | Interferon-γ regulates ClC-2 chloride channel in lung epithelial cells | |
Dry et al. | The complete sequence of the human locus for NgCAM-related cell adhesion molecule reveals a novel alternative exon in chick and man and conserved genomic organization for the L1 subfamily | |
US20020068300A1 (en) | Method for the detection of compounds that modulate the effects of the obese protein | |
US20050271619A1 (en) | Isolated nucleic acid molecules which encode T cell inducible factors, or interleukin-21, the proteins encoded, and uses thereof | |
US20030224456A1 (en) | Method for the detection of compounds that modulate the effects of the obese (OB) protein | |
US20040038315A1 (en) | Novel method | |
Ye et al. | Transcriptional regulation of the mouse interleukin-2 receptor β chain gene by Ets and Egr-1 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
WD01 | Invention patent application deemed withdrawn after publication |